The Scientific Research and Development team at Artios Pharma is dedicated to advancing innovative cancer therapies by exploring the intricacies of the DNA Damage Response (DDR). This multidisciplinary team, comprising experts in biochemistry, medicinal chemistry, and translational science, collaborates to identify and validate novel drug targets, optimize therapeutic candidates, and conduct rigorous preclinical studies. Their efforts aim to translate groundbreaking scientific discoveries into effective treatments for cancer patients.
Aurora Cerutti
Senior Scientist Ii, Team Lead
Chris Lord
Scientific Consultant
Desiree Headley
VP of Clinical Science
Geoff Higgins
Scientific Advisor
Harry Finch
Medicinal Chemistry Consultant
Helen Robinson
VP of Biology
Marina Roy Luzarraga
In Vivo Scientist
Paula Costales
In Vivo Pharmacology. Principa...
Robert Heald
VP of Chemistry
Stephen V. Frye
Scientific Advisor
View all